Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved UPLIZNA® (inebilizumab-cdon) for the treatment of generalized myasthenia gravis (gMG) in adults who ...

Amgen receives US FDA approval for Uplizna to treat Adults with generalized myasthenia gravis: Thousand Oaks, California Saturday, December 13, 2025, 11:00 Hrs [IST] Amgen announc ...

Jonathan Strober, MD, discusses promising results from the VIBRANCE-MG trial, highlighting nipocalimab's safety and efficacy for pediatric myasthenia gravis.

Discover the latest breakthroughs in myasthenia gravis treatment, including rozanolixizumab and nipocalimab, and insights on ...

Amid a swell of regulatory successes in the myasthenia gravis arena this decade, Amgen is wading into the fray with a new indication for its monoclonal antibody Uplizna. Thursday, the FDA greenlighted ...

The FDA expanded the indication of inebilizumab (Uplizna) to include generalized myasthenia gravis (gMG), Amgen announced Friday. The drug is now approved to treat gMG in adults who are ...

In women, heart attacks may not present with the obvious chest pain commonly associated with men. Instead, cardiologists highlight that symptoms such as unusual fatigue, shortness of breath, or ...

Most women today are running on an endless loop—work deadlines, home responsibilities, emotional overload, mental pressure, and the famous “I’ll handle it all” multitasking mode. So when tiredness ...

Menopause symptoms can take a toll on a woman’s health in unexpected ways. The impact goes beyond hot flashes — the symptom probably most associated with the transition. But when doctors asked ...

I am a 76-year-old male who is in relatively good health. For the past six months, I have been experiencing diarrhea on and ...

Many of us imagine a heart attack as a sudden, dramatic event: sharp chest pain, clutching the left side of the chest, and collapsing to the ground. But for many women, including in India, that ...